Clinical Trial Update: FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating FOLFOXIRI plus panitumumab in metastatic RAS wild-type, left-sided colorectal cancer is underway, with status currently unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer Metastatic

Drugs mentioned

• FOLFOXIRI plus panitumumab

Snippet

Sponsor: Criterium, Inc. | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: UNKNOWN